相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection
Lanying Du et al.
JOURNAL OF IMMUNOLOGY (2008)
Increased survival after gemfibrozil treatment of severe mouse influenza
Alison Budd et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection
Rachelle Salomon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
A rationale for using steroids in the treatment of severe cases of H5N1 avian influenza
Marissa J. Carter
JOURNAL OF MEDICAL MICROBIOLOGY (2007)
Apoptosis and pathogenesis of avian influenza A (H5N1) virus in humans
Mongkol Uiprasertkui et al.
EMERGING INFECTIOUS DISEASES (2007)
Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza
Cameron P. Simmons et al.
PLOS MEDICINE (2007)
Efficacy of orally administered T-705 on lethal avian influenza a (H5N1) virus infections in mice
Robert W. Sidwell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice
Kristy J. Szretter et al.
JOURNAL OF VIROLOGY (2007)
A question of self-preservation: immunopathology in influenza virus infection
Nicole L. La Gruta et al.
IMMUNOLOGY AND CELL BIOLOGY (2007)
Drug insight: aminosalicylates for the treatment of IBD
Ole H. Nielsen et al.
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2007)
Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia
Menno D. de Jong et al.
NATURE MEDICINE (2006)
Avian influenza virus infections in humans
SSY Wong et al.
CHEST (2006)
Contrasting effects of cyclooxygenase-1 (COX-1) and COX-2 deficiency on the host response to influenza A viral infection
MA Carey et al.
JOURNAL OF IMMUNOLOGY (2005)
Current concepts - Avian influenza A (H5N1) infection in humans
H Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Virulence may determine the necessary duration and dosage of oseltamivir treatment for highly pathogenic A/Vietnam/1203/04 influenza virus in mice
HL Yen et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Reclinical evaluation of the nonsteroidal anti-inflammatory agent celecoxib on malignant mesothelioma chemoprevention
A Catalano et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Re-emergence of fatal human influenza A subtype H5N1 disease
JSM Peiris et al.
LANCET (2004)
Effect of 5-aminosalicylic acid on radiation-induced micronuclei in mouse bone marrow
MS Kumar et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2003)
Comparison of efficacies of RWJ-270201, zanamivir, and oseltamivir against H5N1, H9N2, and other avian influenza viruses
EA Govorkova et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
5-aminosalicylate stimulates phospholipase D activity in macrophages
A Gómez-Muñoz et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2001)
The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses
IA Leneva et al.
ANTIVIRAL RESEARCH (2000)
Peroxisome proliferator-activated receptors (PPARs): Nuclear receptors at the crossroads between lipid metabolism and inflammation
G Chinetti et al.
INFLAMMATION RESEARCH (2000)
分享论文
